← Back to BMRN

BioMarin Pharmaceutical Inc. financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 05/05/2026Sep 2025Filed 28/10/2025Jun 2025Filed 06/08/2026Mar 2025Filed 05/05/2026Sep 2024Filed 28/10/2025Jun 2024Filed 05/08/2025Mar 2024Filed 02/05/2025
$990$766$776$825$745$746$712$649
$45$106−$31$241$186$106$107$89
$0.23$0.54−$0.16$1.23$0.95$0.55$0.55$0.46
194198192197196197201199

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.